[HTML][HTML] Three distinct mechanisms underlying human γδ T cell-mediated cytotoxicity against malignant pleural mesothelioma
Y Umeyama, H Taniguchi, H Gyotoku, H Senju… - Frontiers in …, 2023 - frontiersin.org
Introduction Malignant pleural mesothelioma (MPM) is a rare and highly aggressive thoracic
tumor with poor prognosis and limited therapeutic options. Although immune checkpoint …
tumor with poor prognosis and limited therapeutic options. Although immune checkpoint …
[PDF][PDF] Three distinct mechanisms underlying human γδ T cell-mediated cytotoxicity against malignant pleural mesothelioma
Y Umeyama, H Taniguchi, H Gyotoku, H Senju… - 2023 - core.ac.uk
Methods: γδ T cells were expanded using tetrakis-pivaloyloxymethyl 2-(thiazole-2-ylamino)
ethylidene-1, 1-bisphosphonate (PTA) and interleukin-2, and the therapeutic potential of γδ …
ethylidene-1, 1-bisphosphonate (PTA) and interleukin-2, and the therapeutic potential of γδ …
Three distinct mechanisms underlying human γδ T cell-mediated cytotoxicity against malignant pleural mesothelioma
Y Umeyama, H Taniguchi, H Gyotoku… - Frontiers in …, 2023 - nagasaki-u.repo.nii.ac.jp
Methods: γδ T cells were expanded using tetrakis-pivaloyloxymethyl 2-(thiazole-2-ylamino)
ethylidene-1, 1-bisphosphonate (PTA) and interleukin-2, and the therapeutic potential of γδ …
ethylidene-1, 1-bisphosphonate (PTA) and interleukin-2, and the therapeutic potential of γδ …
Three distinct mechanisms underlying human γδ T cell-mediated cytotoxicity against malignant pleural mesothelioma
Y Umeyama, H Taniguchi, H Gyotoku… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction Malignant pleural mesothelioma (MPM) is a rare and highly aggressive thoracic
tumor with poor prognosis and limited therapeutic options. Although immune checkpoint …
tumor with poor prognosis and limited therapeutic options. Although immune checkpoint …
Three distinct mechanisms underlying human γδ T cell-mediated cytotoxicity against malignant pleural mesothelioma
Y Umeyama, H Taniguchi, H Gyotoku, H Senju… - Frontiers in …, 2023 - cir.nii.ac.jp
抄録 Introduction: Malignant pleural mesothelioma (MPM) is a rare and highly aggressive
thoracic tumor with poor prognosis and limited therapeutic options. Although immune …
thoracic tumor with poor prognosis and limited therapeutic options. Although immune …
[HTML][HTML] Three distinct mechanisms underlying human γδ T cell-mediated cytotoxicity against malignant pleural mesothelioma
Y Umeyama, H Taniguchi, H Gyotoku… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Methods γδ T cells were expanded using tetrakis-pivaloyloxymethyl 2-(thiazole-2-ylamino)
ethylidene-1, 1-bisphosphonate (PTA) and interleukin-2, and the therapeutic potential of γδ …
ethylidene-1, 1-bisphosphonate (PTA) and interleukin-2, and the therapeutic potential of γδ …
Three distinct mechanisms underlying human γδ T cell-mediated cytotoxicity against malignant pleural mesothelioma
Y Umeyama, H Taniguchi, H Gyotoku… - Frontiers in …, 2023 - europepmc.org
Methods γδ T cells were expanded using tetrakis-pivaloyloxymethyl 2-(thiazole-2-ylamino)
ethylidene-1, 1-bisphosphonate (PTA) and interleukin-2, and the therapeutic potential of γδ …
ethylidene-1, 1-bisphosphonate (PTA) and interleukin-2, and the therapeutic potential of γδ …
Three distinct mechanisms underlying human γδ T cell-mediated cytotoxicity against malignant pleural mesothelioma
梅山泰裕 - Frontiers in Immunology, 2023 - nagasaki-u.repo.nii.ac.jp
Methods: γδ T cells were expanded using tetrakis-pivaloyloxymethyl 2-(thiazole-2-ylamino)
ethylidene-1, 1-bisphosphonate (PTA) and interleukin-2, and the therapeutic potential of γδ …
ethylidene-1, 1-bisphosphonate (PTA) and interleukin-2, and the therapeutic potential of γδ …